A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Public ClinicalTrials.gov record NCT07190196. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult Participants With Active IgG4-related Disease
Study identification
- NCT ID
- NCT07190196
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Interventions
- Glucocorticoid Drug
- Placebo Drug
- Rilzabrutinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 25, 2025
- Primary completion
- Jun 27, 2028
- Completion
- Dec 24, 2030
- Last update posted
- May 3, 2026
2025 – 2030
United States locations
- U.S. sites
- 14
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Jose Clinical Trials- Site Number : 8400016 | San Jose | California | 95128 | Recruiting |
| Solace Clinical Research - Tustin- Site Number : 8400020 | Tustin | California | 92780 | Recruiting |
| Life Clinical Trials - Margate - Colonial Drive- Site Number : 8400002 | Margate | Florida | 33063 | Recruiting |
| Schiff Center for Liver Diseases/University of Miami- Site Number : 8400010 | Miami | Florida | 33136 | Recruiting |
| Vitalia Medical Research - Margate- Site Number : 8400025 | Palm Beach Gardens | Florida | 33410 | Recruiting |
| Primeway Clinical Research- Site Number : 8400019 | Fayetteville | Georgia | 30214 | Recruiting |
| Mayo Clinic in Rochester - Minnesota- Site Number : 8400017 | Rochester | Minnesota | 55905 | Recruiting |
| Cleveland Clinic - Cleveland- Site Number : 8400001 | Cleveland | Ohio | 44195 | Recruiting |
| Ohio State University Wexner Medical Center - Site Number : 8400024 | Columbus | Ohio | 43210 | Recruiting |
| Paramount Medical Research and Consulting LLC- Site Number : 8400018 | Middleburg Heights | Ohio | 44140 | Recruiting |
| Stryde Research- Site Number : 8400011 | Plano | Texas | 75093 | Recruiting |
| Epic Medical Research - Red Oak- Site Number : 8400003 | Red Oak | Texas | 75154 | Recruiting |
| Digestive Health Research of North Texas- Site Number : 8400021 | Wichita Falls | Texas | 76301 | Recruiting |
| Velocity Clinical Research - Seattle- Site Number : 8400005 | Seattle | Washington | 98105 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07190196, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07190196 live on ClinicalTrials.gov.